Pharma Mar | PHM - Net Income


Pharma Mar reported EUR1.53M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.01M 153K Mar/2026
Almirall EUR 19.58M 7M Dec/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Ionis Pharmaceuticals USD -93M 136M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Moderna USD -1.34B 517M Mar/2026
Organon & Co USD 146M 351M Mar/2026
Pharma Mar EUR 1.53M 58.13M Mar/2026
Revvity USD 40.72M 57.65M Mar/2026
Tectonic Therapeutic USD -25.24M 6.02M Mar/2026
Viatris USD 176.4M 516.5M Mar/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026